[1] Pimenta-Barros LA, Ramos-García P, González-Moles MA, et al.Malignant transformation of oral leukoplakia: Systematic review and comprehensive meta-analysis[J]. Oral Dis, 2025, 31(1):69-80. [2] 但红霞, 陈谦明. 口腔黏膜病的光动力治疗[M]. 北京: 人民卫生出版社, 2025. [3] Yan Y, Li Z, Tian X, et al.Laser-assisted photodynamic therapy in proliferative verrucous oral leukoplakia[J]. Photodiagnosis Photodyn Ther, 2022, 39:103002. [4] Jin X, Xu H, Deng J, et al.Photodynamic therapy for oral potentially malignant disorders[J]. Photodiagnosis Photodyn Ther, 2019, 28:146-152. [5] 何宇晴, 但红霞, 陈谦明. 光动力疗法在口腔黏膜癌变防治中的作用[J]. 国际口腔医学杂志, 2020, 47(6): 669-676. [6] Han Y, Ang X, Liu ZJ, et al.Expert Consensus on 5-aminolevulinic Acid Photodynamic Therapy for Oral Potentially Malignant Disorders[J]. Chin J Dent Res, 2025, 28(4):315-322. [7] Zhang R, Gao T, Wang D.Photodynamic therapy(PDT) for oral leukoplakia: a systematic review and meta-analysis of single-arm studies examining efficacy and subgroup analyses[J]. BMC Oral Health, 2023, 23(1):568. [8] Jing Y, Shu R, Wu T, et al.Clinical efficacy of photodynamic therapy of oral potentially malignant disorder[J]. Photodiagnosis Photodyn Ther, 2024, 46: 104026. [9] Wang Y, Tang H, Wang K, et al.Clinical evaluation of photodynamic therapy for oral leukoplakia: a retrospective study of 50 patients[J]. BMC Oral Health, 2024, 24(1):9. [10] Han Y, Xu S, Jin J, et al.Primary Clinical Evaluation of Photodynamic Therapy With Oral Leukoplakia in Chinese Patients[J]. Front Physiol, 2019, 9:1911. [11] Li Y, Wang B, Zheng S, et al.Photodynamic therapy in the treatment of oral leukoplakia: a systematic review[J]. Photodiagnosis Photodyn Ther, 2019, 25:17-22. [12] Chen HM, Yu CH, Tsai T, et al.Topical 5-aminolevulinic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakia[J]. Photodiagnosis Photodyn Ther, 2007, 4(1):44-52. [13] Xu T, Zhong L, Liu Q, et al.NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia[J]. EMBO Mol Med, 2025, 17(7):1794-1824. [14] Gabusi A, Gissi DB, Querzoli G, et al.DNA methylation analysis from oral brushing reveals a field cancerization effect in proliferative verrucous leukoplakia[J]. Pathologica, 2024, 116(6):368-378. [15] Ahn PH, Quon H, O’Malley BW, et al. Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for pre-malignant and early stage head and neck tumors[J]. Oral Oncol, 2016, 55:37-42. [16] van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable?[J]. Med Oral Patol Oral Cir Bucal, 2014, 19(4): e386-e390. [17] Vannucci L.Stroma as an Active Player in the Development of the Tumor Microenvironment. Cancer Microenvironment[J]. Cancer Microenviron, 2015, 8(3):159-166. [18] 韩莹,赵璞,刘宏伟. 细针扣刺预处理联合光动力疗法治疗口腔白斑[J]. 北京大学学报 (医学版), 2025, 57(1):91-96. [19] Shi L, Li C, Shen X, et al.Potential role of autofluorescence imaging in determining biopsy of oral potentially malignant disorders: A large prospective diagnostic study[J]. Oral Oncol, 2019, 98:176-179. [20] Xiao X, Shi L, Li H, et al.DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study[J]. Oral Oncol, 2015, 51(1):59-63. [21] 中华口腔医学会. 口腔白斑病临床诊疗循证指南(T/CHSA 007—2019)[S]. 2019. [22] 中华口腔医学会. 口腔红斑病临床诊疗专家共识(T/CHSA 014—2023)[S]. 2023. [23] Bani-Hani M, Abdel Majid A, Al-Zubi MT, et al.Continuous saline bladder irrigation in reducing recurrence and progression when compared to immediate mitomycin-C instillation post-resection of bladder tumor[J]. Asian Pac J Cancer Prev, 2022, 23(1):171-175. [24] Sasaki M, Okamura M, Ideo A, et al.Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin[J]. Anticancer Res, 2006, 26(5A):3373-3380. |